Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: Diagnostic considerations in the evaluation of liver allografts
Open Access
- 2 February 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 18 (6) , 641-658
Abstract
There is a paucity of data concerning the correlation of complement component 4d (C4d) staining in liver allografts and antibody-mediated rejection. Data about the location and character of C4d deposits in native and allograft liver tissues are inconsistent. We performed C4d immunofluorescence (IF) on 141 fresh-frozen liver allograft biopsy samples and native livers, documented the pattern of C4d IF staining, and correlated the findings with the presence of donor-specific alloantibodies (DSAs). A linear/granular sinusoidal pattern of C4d IF was noted in 18 of 28 biopsy samples obtained after transplantation from patients with positive crossmatch and detectable donor-specific alloantibody (pos-XM/DSA) findings. None of the 59 tested biopsy samples from patients with negative crossmatch and detectable donor-specific alloantibody (neg-XM/DSA) findings were C4d-positive (P < 0.001). No significant association was found between pos-XM/DSA and C4d IF staining in other nonsinusoidal liver compartments. To compare the results of sinusoidal C4d staining with IF and 2 immunohistochemistry (IHC) techniques, C4d IHC was performed on 19 liver allograft biopsy samples in which a sinusoidal pattern of C4d IF had been noted. Sinusoidal C4d IHC findings were negative for 17 of the 19 biopsy samples; 2 showed weak and focal staining, and both patients had pos-XM/DSA findings. Portal vein endothelium staining was present in only 1 IF-stained biopsy sample (pos-XM/DSA) but in 11 IHC-stained biopsy samples (2 of the 11 samples had neg-XM/DSA findings). We conclude that sinusoidal C4d deposits detected by IF in frozen tissue samples from liver allograft recipients correlate with the presence of DSAs and an antibody-mediated alloresponse. These observations are similar to findings reported for other solid organ transplants and can provide relevant information for patient management. Further validation of IHC techniques for C4d detection in liver allograft tissue is required.Keywords
This publication has 35 references indexed in Scilit:
- Complement Component 4D Immunostaining in Liver Allografts of Patients with De Novo Immune HepatitisLiver Transplantation, 2011
- The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver TransplantationAmerican Journal of Transplantation, 2011
- Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodiesLiver Transplantation, 2010
- ELISA-based detection of C4d after liver transplantation — A helpful tool for differential diagnosis between acute rejection and HCV-recurrence?Transplant Immunology, 2010
- Antibody‐mediated rejection of renal allograft in combined liver–kidney transplantClinical Transplantation, 2009
- Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantationWorld Journal of Gastroenterology, 2009
- C4d immunopositivity is uncommon in ABO‐compatible liver allografts, but correlates partially with lymphocytotoxic antibody statusHistopathology, 2007
- Late Humoral Rejection in a Compliant ABO-compatible Liver Transplant RecipientTransplantation, 2006
- Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantationLiver Transplantation, 2006
- Is presensitization relevant to liver transplantation outcome?Human Immunology, 2002